Prosecution Insights
Last updated: April 19, 2026

Arcutis Biotherapeutics Inc.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
0
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18345760 Method and Formulation for Improving Roflumilast Skin Penetration Lag Time SOROUSH, LAYLA 1622 Non-Final OA Jun 30, 2023
18146112 Topical Aerosol Foams WELLES, COLMAN THOMAS 1612 Non-Final OA Dec 23, 2022

Managing Arcutis Biotherapeutics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month